Pharmafile Logo
Pharmafocus logo
Advanced Search
EMA image

Court rules against EMA disclosure

May 2, 2013
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

News
professor_martin_gibson

Not-for-profit comms agency adds special advisor

May 1, 2013
Medical Communications, Sales and Marketing Comprehensive communications

A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …

Appointment

GSK abandons Parkinson’s drug

May 1, 2013
Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …

News
Gilead image

Manufacturing issues block Gilead approvals

May 1, 2013
Manufacturing and Production FDA, Gilead

The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …

News
leigh

Life appoints new executive

May 1, 2013
Medical Communications, Sales and Marketing Anderson, Life

Creative comms agency Life Healthcare Communications has appointed a new account executive as part of the expansion of its client …

Appointment
MS Society web image

Charity: MS treatment is ‘lottery’

May 1, 2013
Sales and Marketing MS, lottery, society

Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …

News

Pfizer sales shrink 9 per cent

April 30, 2013
Sales and Marketing Ian Read, Lipitor, Pfizer

Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …

News

Pfizer and Merck create major diabetes alliance

April 30, 2013
Research and Development, Sales and Marketing Merck, Pfizer, diabetes

Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …

News
Medication passport image

AstraZeneca backs online NHS passport tool

April 30, 2013
Medical Communications, Sales and Marketing NHS, NIHR, app, medication passport

AstraZeneca has provided support to an NHS partner launching an online tool to help patients keep track of their health …

News

‘Solid’ start for Novartis

April 30, 2013
Sales and Marketing Novartis, Q1, sales

Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …

News
hooper

Evolution Marketing Research hires senior director

April 30, 2013
Medical Communications, Research and Development, Sales and Marketing Evolution marketing research, david hooper

Healthcare marketing agency Evolution Marketing Research has appointed David Hooper to the firm as senior director, Research. Hooper brings more …

Appointment
Abbvie image

Sales rise for AbbVie

April 30, 2013
Sales and Marketing AbbVie, Abbott

AbbVie has released its first financial results as a standalone company since separating from Abbott as an $18 billion biopharma …

News
Hunt image

DH acts on private data

April 29, 2013
Medical Communications, Sales and Marketing Hunt, NHS, data

The government has promised that patients will not be forced into having their personal health records shared by doctors and …

News
GSK image

GSK submits UMEC monotherapy

April 29, 2013
Sales and Marketing COPD, EMA, GSK, UMEC

GlaxoSmithKline has put its investigational once-daily medicine umeclidinium bromide (UMEC) up for scrutiny by European regulators for patients with chronic …

News
ctca_-gerard-van-grinsven-90-2-1367000496mr

CTCA changes leadership

April 29, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTCA

The Cancer Treatment Centers of America (CTCA) network has made a change in its executive leadership with the appointment of  …

Appointment

EMA launches ‘black triangle’ post-marketing scheme

April 28, 2013
Sales and Marketing EMA, Post-marketing surveillance, black triangle, pharmacovigilance

The European Medicines Agency has unveiled its new ‘black triangle’ post-marketing surveillance system, and the list of drugs that will …

News

Pfizer’s Xeljanz rejected in Europe

April 28, 2013
Sales and Marketing CHMP, Humira, Pfizer, RA, Xeljanz, rheumatoid arthritis

Pfizer has suffered a major setback with the rejection of its new arthritis drug in Europe.The EMA’s medicines committee the …

News

Prostate cancer drug Xtandi gets nod

April 26, 2013
Sales and Marketing Xtandi, Zytiga, prostate cancer

Astellas and Medivation have received a positive opinion from Europe’s Committee for Medicinal Products for Human Use (CHMP) for Xtandi, …

News
lilly_corporate_hq

Zyprexa decline hits Lilly

April 26, 2013
Sales and Marketing Q1, lilly, zyprexa

Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …

News
knaggs_bio

Stevenage Bioscience Catalyst hires marketing manager

April 26, 2013
Medical Communications, Sales and Marketing Stevenage Bioscience Catalyst

Open innovation bioscience campus Stevenage Bioscience Catalyst, has announced the appointment of Miranda Knaggs as Marketing, Sales & Events manager. …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026